carnival of journalism | Mark Coddington

List

May 5th, 2011

Tramadol Cost

Tramadol Cost, I've mostly watched the Carnival of Journalism's rebirth from afar, but this month's prompt was just too tempting to stay on the sidelines this time around. Here's the prompt:

A failure in your life (personal or professional) that has lessons. It must be your failure and you must take responsibility. But this will be a safe space to discuss our failings and what we can learn from them.

My fail comes from about eight years ago, when I was a wide-eyed underclassman at Wheaton College in Illinois. I came into school relatively certain that I wanted to be a journalist, After Tramadol, having been inspired by the brilliant pieces in the Sports Illustrateds that arrived at my home each week through middle and high school. Wheaton didn't have a journalism program (or even a full-time journalism professor), but that didn't bother me, Tramadol Cost. As far as I was concerned, my career path was set: I would go to Wheaton, gradually get involved in the student newspaper, go to a j-school somewhere for a master's and my "real" journalism education, and emerge, ready for a full-time reporting gig at either Sports Illustrated or The New York Times, Tramadol blogs, or maybe, if I really had to settle, the Washington Post. Easy.

The first step was starting at the student newspaper: I went to their recruiting meeting at the beginning of my freshman year, Tramadol pharmacy, and timidly told the sports editor I was interested in writing for them. The response was encouraging — they had a real need for sportswriters, and they could put me on pretty much any sport I wanted right away; only football had been claimed. Tramadol Cost, I wanted to ease into everything, so I specifically asked for the lowest-profile sports they regularly wrote about, and ended up with women's basketball (and even that was pushing it a bit too far into high-profile territory for my tastes) and tennis. The next year, I added volleyball and replaced tennis with baseball.

So here's the fail: I was quite possibly the worst sports reporter you or I have ever read. Oh, I was technically proficient: I knew where to put commas and periods and how to string sentences together into a story, Tramadol price. But as a journalist, I was terrible. You know how many athletes I talked to in my two years of sports reporting. One, Tramadol Cost. One. And he lived in the dorm room next door to me. Tramadol samples, Every week, I would set up an interview in the office of the coach I was covering, find out how their team was doing, what was coming up on the schedule and so on. Every week, I would try to watch a home game — not really because they actually informed my stories, but mostly because I kind of knew that if I didn't even attend the games of the team I was covering, Tramadol street price, then I wouldn't be able to fool myself anymore about how terrible of a job I was doing. Tramadol Cost, And every week, I would start my story with the same exact Mad Lib formula: "The Wheaton [SPORT] team [VERBED] this week, [VERBING] a [CONFERENCE RANK OR WINNING/LOSING STREAK]."

This is not an exaggeration. Every week: Summary of games drawn from boxscores, rote quotes from coaches, more summary, list of games coming up this week. Tramadol australia, uk, us, usa, That's it. For two years. I made the sportswriting robot look like Grantland Rice.

And here's the weird thing: I knew my stories were terrible, and I wrote them that way anyway, Tramadol Cost. I wasn't stupid; I had read tons of incredible sportswriting, and I knew that my stories had absolutely nothing in common with them.

So why did I persist in my head-scratching awfulness. Two reasons: Because I was scared, Tramadol pics, and because I believed in the journalism fairy. The fear part is easy to explain. Tramadol Cost, I was terrified of interviewing people, and I was terrified of having my peers read my writing. I didn't want to inconvenience or annoy people by asking them awkward questions, and I found the idea of walking up and interrogating someone to be incredibly intimidating. And I didn't want my friends to see me do poorly at something they knew I was passionate about: I desperately wanted for there to be a way I could learn journalism entirely in private, Fast shipping Tramadol, without ever having the chance to fail in public.

Here's what I mean by the journalism fairy: I had this idea that the secret knowledge of how to be an awesome journalist would just magically be bestowed on me eventually. All I had to do was try to keep doing a few journalism-ish things for a while, and suddenly the magic dust would come down, the lightbulb would go on and I'd be a brilliant reporter. After all, I knew I could write, and I could think critically, Tramadol Cost. At some point, I figured, Tramadol no prescription, those two skills would come together, and abacadabra, I'd be transformed into an amazing journalist.

This, of course, Order Tramadol from mexican pharmacy, is ludicrous. But it kept me from learning and doing real journalism for two years, and now, as a TA for journalism undergrads, I sometimes suspect that this idea has infected the minds of some of my students. They have dreams of being high-profile journalists someday, but they're too timid or unmotivated to do any real journalism now, Tramadol price, coupon, while they're in school specifically to learn it. Tramadol Cost, So here's the moral of my failure, especially for journalism students: There is no secret knowledge of journalism, and it will never be magically bestowed on you. There's only one way to become a good journalist — going out, doing it, and then going out and doing it some more. There are no shortcuts. The best young journalists I know attacked their journalism educations, Comprar en línea Tramadol, comprar Tramadol baratos, wringing every last drop of experience out of their four (or five, or six) years in school. And one of my biggest regrets about my own college experience is that I didn't do that.

That doesn't mean you need to get hyper-competitive about your journalism education, nor does it mean there's no room for failure or for trying new experiences that don't have anything to do with journalism. Those latter two are what journalism's all about: doing, Tramadol Cost. Go, take the tough assignment from your student newspaper, online buy Tramadol without a prescription. Talk to the sources that intimidate you. Put yourself out there for internships and freelance work. Jump in with the new on-campus media startup. Take the semester overseas. Sometimes you'll fail, Tramadol alternatives, and you might even find out that journalism's not what you want to do after school. But even if that happens, at least you went out and found out yourself, rather than waiting for the journalism fairy to sprinkle Woodward and Bernstein dust on you. Because as I found out, you're gonna be waiting for that fairy for a loooooong time.

April 3rd, 2011

Bactrim For Sale

[This review was originally posted at the Nieman Journalism Lab Bactrim For Sale, on April 1, 2011.]

Putting the Times' pay plan in place: If you read last week's review, the first half of this week's should feel like déjà vu — lots of back-and-forth about the wisdom of The New York Times' new online pay plan, and some more hand-wringing about getting around that plan. If you want to skip that and get to the best stuff, I recommend Staci Kramer, David Cohn, and Megan Garber.

The Times launched its pay system Monday with a letter to its readers (snarkier version courtesy of Danny Sullivan), along with a 99-cent trial offer for the first four weeks and free access for people who subscribe to the Times on Kindle, Bactrim price. Times digital chief Martin Nisenholtz gave a launch-day talk to newspaper execs, highlighted by his assertion that the link economy is not a win-win for content producers and aggregators.

Meanwhile, the discussion about the paywall's worth rolled on. You can find a good cross-section of opinions in this On Point conversation with Ken Doctor, the Journal Register's John Paton, The Times' David Carr, and NYTClean creator David Hayes, Bactrim For Sale. The plan continues to draw support from some corners, Get Bactrim, including The Onion (in its typically ironic style, of course) and PC Magazine's Lance Ulanoff. Former Financial Times reporter Tom Foremski and Advertising Age columnist Simon Dumenco both made similar arguments about the value of the plan, where can i buy cheapest Bactrim online, with Foremski urging us to support the Times as a moral duty to quality journalism and Dumenco ripping the blogosphere's paywall-bashers for not doing original reporting like the Times.

And though the opposition was expressed much more strongly the past two weeks, there was a smattering of dissent about the plan this week, too — some from the Times' mobile users. One theme among the criticism was the cost of developing the plan: Philip Greenspun wondered how the heck the Times spent $40 million on planning and implementation, and former Guardian digital head Emily Bell wrote about the opportunity cost of that kind of investment. Rx free Bactrim, BNET's Erik Sherman proposed that the Times should have invested the money in innovation instead.

A few other interesting thoughts about the Times' pay plan before we get to the wall-jumping debate: Media consultant Judy Sims said the plan might actually make the Times more social Bactrim For Sale, by providing an incentive for subscribers to share articles on social networks to their non-subscribing friends. Spot.Us' David Cohn argued that the plan is much closer to a donation model than a paywall and argued for the Times to offer membership incentives. And Reuters' Felix Salmon talked about how the proposal is changing blogging at the Times.

PaidContent's Staci Kramer said the Times is fighting an uphill battle in the realm of public perception, but that struggle is the Times' own fault, created by its way-too-complicated pay system.

—

The ethics of paywall jumping: With the Times' "pay fence" going into effect, Bactrim pictures, all the talk about ways to get around that fence turned into a practical reality. Business Insider compiled seven of the methods that have been suggested: A browser extension, Twitter feeds, using different computers, NYTClean and a User Script's coding magic, Google (for five articles a day), and browser-switching or cookie-deleting, Bactrim For Sale. Mashable came up with an even simpler one: delete "?gwh=numbers" from the Times page's URL.

Despite such easy workarounds, the Times is still cracking down in other areas: As Search Engine Land's Danny Sullivan noted, it blocks links from all Google sites after the five-articles-per-day limit is reached. Bactrim price, coupon, The Times also quickly (and successfully) requested a shutdown of one of the more brazen free-riding schemes yet concocted — NYT for a Nickel, which charged to access Times articles without paywall restrictions. (It did, however, let up on unauthorized Twitter aggregators of Times content.)

So we all obviously can crawl through the Times' loopholes, but should we. A few folks made efforts to hack through the ethical thicket of the Times' intentional and unintentional loopholes: Times media critic James Poniewozik didn't come down anywhere solid Bactrim For Sale, , but said the Times' leaky strategy "makes the paywall something like a glorified tip jar, on a massive scale—something you choose to contribute to without compulsion because it is the right thing" — except unlike those enterprises, it's for-profit. In a more philosophical take, the Lab's Megan Garber said the ethical conundrum shows the difficulty of trying to graft the physical world's ethical assumptions onto the digital world.

—

A possible +1 for publishers: Google made a big step in the direction of socially driven search this week with the introduction of +1, purchase Bactrim online, a new feature that allows users to vote up certain search results in actions that are visible to their social network. Here are two good explainers of the feature from TechCrunch and Search Engine Land, both of whom note that +1's gold mine is in allowing Google to personalize ads more closely, and that it's starting on search results and eventually moving to sites across the web.

The feature was immediately compared to Facebook's "Like" and Twitter's retweets, Bactrim no rx, though it functions a bit differently from either. As GigaOM's Mathew Ingram noted, because it's Google, it's intrinsically tied to search, which is both an advantage and a disadvantage. As Ingram said, it's smart to add more of a social component to search, but Google's search-centricity makes the "social network" aspect of +1 awkward, just as Buzz and Wave were, Bactrim For Sale. To paraphrase the argument of Frederic Lardinois of NewsGrange: if your +1's go into your Google Profile and no one sees them, do they really make a sound, generic Bactrim.

All this seems to be good news for media sites. Lost Remote's Cory Bergman said that if they essentially become "improve the SEO of this site" buttons, media companies will be pretty motivated to add them to their sites. Likewise, Poynter's Damon Kiesow reasoned that +1 could be a great way for media sites to more deeply involve visitors who arrive via Google, Bactrim duration, who have typically been less engaged than visitors from Facebook and Twitter.

—

Shrinking innovation to spur it: This month's Carnival of Journalism Bactrim For Sale, focuses on how to drive innovation, specifically through the Knight News Challenge and Reynolds Journalism Institute. Most of the posts rolled in yesterday, and they contain a litany of quick, smart ideas of new directions for news innovation and how to encourage it.

A quick sampling: City University London and Birmingham City University j-prof Paul Bradshaw proposed a much broader, smaller-scale News Challenge fund, with a second fund aimed at making those initiatives scale, where can i buy Bactrim online. J-Lab Jan Schaffer said we need to quit looking at innovation so much solely in terms of tools and more in terms of processes and relationships. British journalist Mary Hamilton and Drury j-prof Jonathan Groves both focused on innovation in training, with Groves proposing "innovation change agents" funded by groups like Knight and the RJI to train and transform newsrooms.

Also, University of British Columbia j-prof Alfred Hermida opined on the role of theory in innovation, Lisa Williams of Placeblogger advocated a small-scale approach to innovation, and the University of Colorado's Steve Outing had some suggestions for the RJI fellowship program, Bactrim For Sale.

—

The mechanics of Twitter's information flow: Four researchers from Yahoo and Cornell released a study this week analyzing, as they called it, Buy Bactrim no prescription, "who says what to whom on Twitter." One of their major findings was that half the information consumed on Twitter comes from a group of 20,000 "elite" users — media companies, celebrities, organizations and bloggers. As Mathew Ingram of GigaOM observed, that indicates that the power law that governs the blogosphere is also in effect on Twitter, and big brands are still important even on a user-directed platform, Bactrim no prescription.

The Lab's Megan Garber noted a few other interesting implications of the study, delving into Twitter's two-step flow from media to a layer of influential sources to the masses, as well as the social media longevity of multimedia and list-oriented articles. A couple of other research-oriented items about Twitter: A Lab post on Dan Zarrella's data regarding timing and Twitter posts, and Maryland prof Zeynep Tufekci wrote a more theoretical post on NPR's Andy Carvin and the process of news production on Twitter.

—

Reading roundup: Plenty of other bits and pieces around the future-of-news world this week:

— New York Times editor Bill Keller wrote a second column Bactrim For Sale, , and like his anti-aggregation piece a couple of weeks ago, this piece — about the value of the Times' impartiality and fact-based reporting — didn't go over well. Buy Bactrim without prescription, Reuters' Felix Salmon called him intellectually dishonest, Scott Rosenberg called him defensive, and the Huffington Post's Peter Goodman (a former Times reporter) said Keller misrepresented him.

— A few notes on The Daily: Forbes' Jeff Bercovici said it was downloaded 500,000 times during its trial period and has 70,000 regular users, and a study was conducted finding that it's more popular with less tech-savvy, purchase Bactrim for sale, less content-concerned users.

— Journal Register Co. CEO John Paton talked about transforming newspapers at the Newspaper Association of America convention; he summarized what he had to say in 10 tweets, and Alan Mutter wrote a post about the panel. The moderator, Ken Doctor, wrote a Lab post looking at how long newspapers have left.

— I'll send you off with Jonathan Stray's thoughtful post on rethinking journalism as a system for informing people, rather than just a series of stories. It's a lot to chew on, but a key piece to add to the future-of-news puzzle.

March 16th, 2011

Bactrim No Rx

[This review was originally posted at the Nieman Journalism Lab Bactrim No Rx, on Feb. 25, 2011.]

The short, happy-ish life of TBD: Just six months after it launched and two weeks after a reorganization was announced, the Washington, D.C., local news site was effectively shuttered this week, where can i buy cheapest Bactrim online, when its corporate parent, Allbritton Communications (it's owned by Robert Allbritton and includes Politico), cut all of its jobs, leaving only an arts and entertainment operation within the website of Allbritton's WJLA-TV.

TBD had been seen many as a bellwether in online-only local news, After Bactrim, as Poynter's Mallary Jean Tenore documented in her historical roundup of links about the site, so it was quite a shock and a disappointment to many future-of-newsies that it was closed so quickly. The response — aptly compiled by TBDer Jeff Sonderman — was largely sympathetic to TBD's staff (former TBD manager Jim Brady even wrote a pitch to prospective employers on behalf of the newly laid off community engagement team). Many observers on Twitter (and Terry Heaton on his blog) pointed squarely at Allbritton for the site's demise, with The Batavian's Howard Owens drawing out a short, thoughtful lesson: "Legacy managers will nearly always sabotage innovation. Wall of separation necessary between innovators and legacy."

Blogger Mike Clark pointed out that TBD's traffic was beating each of the other D.C. TV news sites and growing as well, Bactrim No Rx. The Washington Post reported that while traffic wasn't a problem, Bactrim blogs, turning it into revenue was — though the fact that TBD's ads were handled by WJLA staffers might have contributed to that.

Mallary Jean Tenore wrote an insightful article talking to some TBD folks about whether their company gave them a chance to fail. Lehigh j-prof Jeremy Littau was unequivocal on the subject: "Some of us have been talking today on Twitter about whether TBD failed. Nonsense. TBD wasn’t given enough time to fail."

While CUNY j-prof Jeff Jarvis lamented Bactrim No Rx, that "TBD will be painted as a failure of local news online when it's a failure of its company, nothing more," others saw some larger implications for other online local news projects. Media analyst Alan Mutter concluded that TBD's plight is "further evidence that hyperlocal journalism is more hype than hope for the news business, Order Bactrim from United States pharmacy, " and Poynter's Rick Edmonds gave six business lessons for similar projects from TBD's struggles. Journal Register Co. CEO John Paton ripped Edmonds' analysis, arguing that Allbritton "can’t pretend to have seriously tried the hyperlocal business space after a six-month experiment it derailed half-way in."

—

Applying Apple's new rules: Publishers' consternation over Apple's new subscription plan for mobile devices continued this week, with Frederic Filloux at Monday Note laying out many publishers' frustrations with Apple's proposal. The New York Times' David Carr and The Guardian's Josh Halliday both covered publishers' Apple subscription conundrum, and one expert told Carr, Bactrim over the counter, "If you are a publisher, it puts things into a tailspin: The business model you have been working with for many years just lost 30 percent off the top."

At paidContent, James McQuivey made the case for a lower revenue share for Apple, and Dan Gillmor wondered whether publishers will stand up to Apple. The company may also be facing scrutiny from the U.S, Bactrim No Rx. Justice Department and Federal Trade Commission for possible antitrust violations, Buy Bactrim without a prescription, The Wall Street Journal reported.

The fresh issue regarding Apple's subscription policy this week, though, was the distinction between publishing apps and more service-oriented apps. The topic came to the fore when the folks from Readability, an app that allows users to read articles in an advertising-free environment, wrote an open letter ripping Apple for rejecting their app, buying Bactrim online over the counter, saying their new policy "smacks of greed." Ars Technica's Chris Foresman and Apple blogger John Gruber noted, though, that Readability's 30%-off-the-top business model is a lot like Apple's.

Then Apple's Steve Jobs sent a short, cryptic email to a developer saying that Apple's new policy applies only to publishing apps, Rx free Bactrim, not service apps. Bactrim No Rx, This, of course, raised the question, in TechCrunch's words, "What's a publishing app?" That's a very complex question, and as Instapaper founder Marco Arment wrote, one that will be difficult for Apple to answer consistently. Arment also briefly noted that Jobs' statement seems to contradict the language of Apple's new guidelines.

—

Giving voice to new sources of news: This month's Carnival of Journalism, posted late last week, focused on ways to increase the number of news sources. It's a broad question, and it drew a broad variety of answers, Bactrim schedule, which were ably summarized by Courtney Shove. I'm not going to try to duplicate her work here, but I do want to highlight a few of the themes that showed up.

David Cohn, the Carnival's organizer, gave a great big-picture perspective to the issue, putting it in the context of power and the web. Kim Bui and Dan Fenster defended the community-driven vision for news, with Bui calling journalists to go further: "Let’s admit it, we’ve never trusted the public." There were several calls for journalists to include more underrepresented voices, with reports and ideas like a refugee news initiative, digital news bus, youth journalism projects, and initiatives for youth in foreign-language families, Bactrim No Rx.

The J-Lab's Jan Schaffer gave 10 good ideas to the cause, and Drury j-prof Jonathan Groves and Gannett's Ryan Sholin shared their ideas for local citizen news projects, Bactrim australia, uk, us, usa, while TheUpTake's Jason Barnett endorsed a new citizen-journalism app called iBreakNews.

Three bloggers, however, objected to the Carnival's premise in the first place. Daniel Bachhuber of CUNY argued that improving journalism doesn't necessarily mean adding more sources, recommending instead that "Instead of increasing the number of news sources, we should focus on producing durable data and the equivalent tools for remixing it." Lauren Rabaino warned against news oversaturation, order Bactrim no prescription, and the University of Colorado's Steve Outing said that more than new sources, we need better filters and hubs for them.

—

Blogging's continued evolution: The "blogging is dead" argument has popped up from time to time, and it was revived again this week in the form of a New York Times story about how young people are leaving blogs for social networking sites like Facebook and Twitter. Bactrim No Rx, Several people countered the argument, led by GigaOM's Mathew Ingram, who said that blogging isn't declining, but is instead evolving into more of a continuum that includes microblogging services like Twitter, traditional blog formats like Wordpress, and the hybrid that is Tumblr. He and Wordpress founding developer Matt Mullenweg shared the same view — that "people of all ages are becoming more and more comfortable publishing online," no matter the form.

Scott Rosenberg, who's written a history of blogging, looked at statistics to make the point, noting that 14% of online adults keep a blog, buy Bactrim online no prescription, a number he called astounding, even if it starts to decline. "As the online population becomes closer to universal, that is an extraordinary thing: One in ten people writing in public. Our civilization has never seen anything like it." In addition, Bactrim treatment, Reuters' Anthony DeRosa argued that longer-form blogging has always been a pursuit of older Internet users.

—

Reading roundup: I've got a few ongoing stories to update you on, and a sampling of an unusually rich week in thoughtful pieces.

— A couple of sites took a peek at Gawker's traffic statistics to try to determine the effectiveness of its recent redesign, Bactrim No Rx. TechCrunch saw an ugly picture; Business Insider was cautiously optimistic based on the same data. Gawker disputed TechCrunch's numbers, and Terry Heaton tried to sort through the claims.

— A couple of Middle East/North Africa protest notes: The New York Times told us about the response to Egypt's Internet blackout and the role of mobile technology in documenting the protests, is Bactrim safe. And Amy Gahran of the Knight Digital Media Center gave some lessons from the incredible Twitter journalism of NPR's Andy Carvin.

— The Daily is coming to Android tablets Bactrim No Rx, this spring, and its free trial run has been extended beyond the initial two weeks.

— Matt DeRienzo of the Journal Register Co. wrote about an intriguing idea for a news org/j-school merger.

— Alan Mutter made the case for ending federal funding for public journalism.

— At 10,000 Words, Lauren Rabaino had some awesome things news organizations can learn from tech startups, including thinking of news as software and embracing transparency.

— And here at the Lab, Northwestern prof Pablo Boczkowski gave some quick thoughts on how we tend to associate online news with work, and what that means. He sheds some light about an under-considered aspect of news — the social environments in which we consume it.

February 18th, 2011

Retin A For Sale

[This review was originally posted at the Nieman Journalism Lab Retin A For Sale, on Jan. 21, 2011.]

Huge merger, big reservations: One of the biggest media deals of the past decade got its official go-ahead when the Federal Communications Commission approved the proposed merger between Comcast and NBC Universal. As Ars Technica noted, the deal's scope is massive: In addition to being the nation's largest cable provider, the new company will control numerous cable channels, plus the NBC television network, buy Retin A no prescription, Universal Studios, Universal theme parks, and two professional sports teams.

The new company will also retain a stake in the online TV site Hulu (which NBC co-founded with News Corp.), though it agreed to give up its management role as one of the conditions the FCC placed on its approval. Lost Remote's Steve Safran called the requirement a forward-thinking move by the FCC, Retin A use, given how far Comcast's content outpaces Hulu's right now. Another of the conditions also protects Bloomberg TV from being disadvantaged by Comcast in favor of its new property, CNBC, Retin A For Sale.

The decision had plenty of detractors, starting with the FCC's own Michael Copps, who wrote in his dissenting statement that the deal could lead to the "cable-ization of the Internet." "The potential for walled gardens, toll booths, content prioritization, access fees to reach end users, and a stake in the heart of independent content production is now very real, canada, mexico, india," he said. In the current issue of The Columbia Journalism Review, John Dunbar wrote a more thorough critique of the deal, arguing that it's old media's last-gasp attempt to stave off the web's disruption of television. Josh Silver and Josh Stearns of the media reform group both penned protests, too.

A few other angles: GigaOM's Liz Shannon Miller looked at the FCC's emphasis on online video, Retin A from canada, and All Things Digital's Peter Kafka explained why the deal might make it more difficult to give up cable. Finally, Steve Myers of Poynter examined NBC's agreement as part of the merger to create new partnerships between some of its local stations and nonprofit news organizations.

—

Rethinking j-school Retin A For Sale, : The Carnival of Journalism, an old collaborative blogging project, was revived this month by Spot.Us founder (and fellow at Missouri's Reynolds Journalism Institute) David Cohn, who directed participants to blog about the Knight Foundation's call for j-schools to increase their role as "hubs of journalistic activity" and integrate further integrate media literacy into all levels of education.

The posts came rolling in this week, and they contained a variety of ideas about both the journalistic hubs component and the media literacy component. The latter point was expounded on most emphatically by Craig Silverman, who laid out a vision for the required course "Bullshit Detection 101," teaching students how to consume media (especially online) with a keen, Retin A cost, skeptical eye. "The Internet is the single greatest disseminator of bullshit ever created. The Internet is also the single greatest destroyer of bullshit," he wrote.

CUNY j-prof C.W. Anderson pointed to a 2009 lecture in which he argued for education about the production of media (especially new media) to be spread beyond the j-school throughout universities, and Memphis j-prof Carrie Brown-Smith noted that for students to learn new media literacy, the professors have to be willing to learn it, Retin A dose, too. Politico reporter Juana Summers made the case for K-12 media literacy education, and POLIS director Charlie Beckett talked about going beyond simplistic concepts of media literacy, Retin A For Sale.

There were plenty of proposals about j-schools as journalistic hubs, as well. City University, London j-prof Paul Bradshaw wrote about the need for j-students to learn not just how to produce journalism, but how to facilitate its production by the community. Megan Taylor tossed out a few ideas, too, where can i order Retin A without prescription, including opening student newspapers up to the community, and J-Lab editorial directorAndrew Pergam and CUNY's Daniel Bachhuber looked at the newsroom cafe concept and NYU's The Local: East Village, respectively, as examples for j-schools. Cohn chimed in with suggestions on how to expand the work of journalism beyond the j-school and beyond the university, and Central Lancashire j-prof Andy Dickinson argued that j-schools should serve to fill the gaps left by traditional media.

A few more odds and ends from the Carnival of Journalism: Minnesota j-prof Seth Lewis urged j-schools Retin A For Sale, to create more opportunities for students to fail, Cornell grad student Josh Braun pondered how the rise of online education might play into all this, and Rowan j-prof Mark Berkey-Gerard listed some of the challenges of student-run journalism. Retin A overnight, —

A pro-paywall data point: One of the biggest proponents of paid news online lately has been Steven Brill, whose Journalism Online works with news organizations to charge for content online. This week, Brill publicized findings from his first few dozen efforts that found that with a metered model (one that allows a certain number of articles for free, then charges for access beyond that), traffic didn't decline dramatically, as they were expected to. The New York Times — a paper that's planning a metered paid-content model — wrote about the results, Retin A images, and a few folks found it encouraging.

Others were skeptical — like The Columbia Journalism Review's Ryan Chittum, who wondered why the story didn't include information about how many people paid up online and how much revenue the paywalls generated. Rick Edmonds of Poynter pointed out the same thing, and tied the story to a recently announced paywall at the Dallas Morning News and tweaks at Honolulu Civil Beat's paywall, Retin A For Sale.

Elsewhere in the world of paid news content, Michele McLellan of the Knight Digital Media Center talked to the editor of the Waco (Texas) Tribune-Herald about his newspaper's paywall experiment.

—

Cracking the iPad's subscription code: Publishers' initial crush on the iPad seems to be fading into ambivalence: The New York Times reported this week that magazines publishers are frustrated with Apple's harsh terms in allowing them to offer iPad subscriptions and are beginning to look to other forthcoming tablets instead. Herbal Retin A, Apple is cracking down overseas, too, reportedly telling European newspapers that they can't offer a free iPad edition to print subscribers.

One publication is about to become one of the first to seriously test Apple's subscription model — Rupert Murdoch's much-anticipated The Daily. Advertising Age reported Retin A For Sale, on the expectations and implications surrounding The Daily, and the Lab's Ken Doctor took a look at The Daily's possible financial figures. Mashable's Lauren Indvik, meanwhile, wondered how The Daily will handle the social media portion of the operation.

In other iPad news, Retin A no rx, a survey reported on by Advertising Age found that while iPad users don't like ads there, they might welcome them as an alternative to paid apps. The survey also suggested, interestingly enough, that the device is being used a lot like home computers, with search and email dominating the uses and usage of media apps like books and TV lagging well behind that. Retin A wiki, Business Insider also reported that AOL is working on a Flipboard-esque iPad app that tailors news around users' preferences.

—

Reading roundup: Tons of other stuff going on this week, Retin A For Sale. Here's a sampling:

— Two titans of the tech industry, Apple's Steve Jobs and Google's Eric Schmidt — announced this week they would be stepping down (Jobs is taking a temporary medical leave; Schmidt stepping down as CEO but staying on as an adviser). Both were massive tech stories, and Techmeme has more links for you on both than I could ever intelligently direct you to.

— Another huge shakeup, this in the media world: Dean Singleton, co-founder of the bankrupt newspaper chain MediaNews, Retin A long term, will step down as its CEO. Both Ken Doctor and the Lab's Martin Langeveld saw Alden Global Capital's fingerprints all over this and other newspaper bankruptcy shakeups, with Langeveld speculating about a possible massive consolidation in the works. Retin A For Sale, — As I noted last week, Wikipedia celebrated its 10th anniversary last Saturday, prompting several reflections late last week. A few I that missed last week's review: Clay Shirky on Wikipedia's "ordinary miracle," The New York Times on Wikipedia's history, and Jay Rosen's comparison of Wikipedia and The Times. Retin A description, — Pew published a survey on the social web, and GigaOM's Mathew Ingram and The Atlantic's Jared Keller both offered smart summaries of the Internet's remarkable social capacity, with Keller tying it to Robert Putnam's well-known thoughts on social capital.

— A few addenda to last week's commentary about the Tucson shooting: How NPR's errant reporting hurt the families involved, j-prof Jeremy Littau on deleting incorrect tweets, Mathew Ingram on Twitter's accuracy in breaking news, and the Project for Excellence in Journalism's study of the shooting's coverage.

— Finally, Retin A street price, a wonderful manifesto for journalists by former Guardian editor Tim Radford. This is one you'll want to read, re-read, and then probably re-read again down the road.

Mark Coddington

Associate Professor, Washington and Lee University

Tramadol Cost

Bactrim For Sale

Bactrim No Rx

Retin A For Sale